Dr. Reddy's Laboratories shares rally 1.42% amid positive market session
Updated
Updated · MarketWatch · Apr 27
Dr. Reddy's Laboratories shares rally 1.42% amid positive market session
12 articles · Updated · MarketWatch · Apr 27
The stock closed at 1,334.55 rupees on Monday, outperforming the BSE SENSEX Index, which rose 0.83% to 77,303.63.
Dr. Reddy's shares remain 3.15% below their 52-week high of 1,377.95 rupees set on June 12th, with trading volume at 60,847, below the 50-day average.
Competitors Lupin and Zydus Lifesciences also posted gains, while Wockhardt rose 2.30%. The session reflects broad market optimism driving pharmaceutical stocks higher.
Can Dr. Reddy's win India's generic weight-loss drug price war against deep-discounting rivals?
Will Novo Nordisk's patent defenses derail Dr. Reddy's global ambitions for its new generic?
Why are top analysts issuing 'Sell' ratings despite the landmark generic Ozempic launch?
After past industry scandals, can Indian generics guarantee the quality of complex drugs like semaglutide?
As foreign investors exit, is the stock surge a sign of strength or a trap for local buyers?